Morganella morganii

It's a common inhabitant of the human gut, but Morganella morganii is a formidable opportunistic pathogen. This bacterium is notorious for causing complex urinary tract infections (UTIs), post-operative wound infections, and bacteremia, particularly in hospitalized or immunocompromised patients. What makes it such a clinical challenge? Its inducible AmpC beta-lactamase, which can lead to treatment failure if not properly identified. This comprehensive explainer is your guide to M. morganii. We'll break down the essential laboratory characteristics for accurate identification, explore the full spectrum of clinical diseases it causes, and dive deep into its complex antimicrobial resistance mechanisms. We'll also cover the latest evidence-based treatment guidelines, including when to use carbapenems and how to navigate its inducible resistance. This video was made with Gemini's deep research capabilities and NotebookLM. Explore our research and sources for this video in our NotebookLM document: https://notebooklm.google.com/noteboo... Timestamps: 00:00 - Introduction: The Opportunistic Threat 01:03 - Chapter 1: Identification in the Lab 02:15 - Chapter 2: Clinical Spectrum (UTI, Wounds, Sepsis) 03:30 - Chapter 3: The AmpC Resistance Problem 04:45 - Chapter 4: Treatment Guidelines 05:50 - Chapter 5: Infection Control & Prevention If you found this video helpful, please like and subscribe for more clinical microbiology deep dives. What are your institution's protocols for dealing with inducible AmpC producers? Share your experiences in the comments below! #MorganellaMorganii #Morganella #Microbiology #InfectiousDisease #ClinicalMicrobiology #AntimicrobialResistance #AMR #AmpC #UTI #Sepsis #Bacteriology #MedicalEducation #LabMedicine #HospitalInfection #EUCAST